eMedicine Specialties > Vascular Surgery > Medical Topics

Arteriovenous Malformations

Author: Steven L Lee, MD, Chief, Pediatric Surgery, Department of Surgery, Kaiser-Permanente, Los Angeles Medical Center
Coauthor(s): Devin P Puapong, MD, Fellow, Division of Pediatric Surgery, University of Oklahoma Health Sciences Center; Jeffrey J DuBois, MD, Consulting Staff, Division of Pediatric Surgery, Kaiser Permanente, North Sacramento Medical Center
Contributor Information and Disclosures

Updated: May 18, 2009

Introduction

Background

Vascular anomalies are among the most common congenital abnormalities observed in infants and children. Unfortunately, these lesions are also among the most confusing and misunderstood conditions, largely because of a history of inconsistent terminology used for classification. Commonly accepted names have been based on external appearance, such as strawberry nevus1,2 cherry hemangioma, and port-wine stain,3,4 or based on histology, such as capillary hemangioma, cavernous hemangioma,5 and arteriovenous fistula. However, lesions with a similar appearance may have markedly different growth patterns; conversely, lesions that are biologically identical may differ greatly in external appearance because of the location and depth of the lesion. Thus, the most clinically applicable and simplest classification scheme is based on the biological activity of the blood vessels contained in these lesions.


An intramuscular arteriovenous malformation. This...

An intramuscular arteriovenous malformation. This enlarging lesion resulted in compression and atrophy of noninvolved muscle within the compartment.

An intramuscular arteriovenous malformation. This...

An intramuscular arteriovenous malformation. This enlarging lesion resulted in compression and atrophy of noninvolved muscle within the compartment.


This classification system, proposed by Mulliken and Glowacki,6 divides vascular anomalies into lesions that are biologically active (hemangiomas)7 and those that are not (vascular malformations).8 The goal of this article is to clarify the differences between hemangiomas and vascular malformations by reviewing the clinical characteristics, diagnosis, and treatment options of both types of conditions. Once the distinctions are understood, clinicians will be able to accurately describe the expected course of these particular lesions to parents.

Pathophysiology

The varied origins of vascular tumors include true neoplastic growth, structural malformations, and hamartomatous transformations. The specific underlying biologic process forms the principal foundation of Mulliken and Glowacki's classification of this broad class of lesions.6

The rapidly progressive nature of hemangiomas intimates a neoplastic process; however, the precise point in fetal, embryonic, or postnatal development that gives rise to hemangiomas remains elusive. Whether hemangiomas represent embryonic mesodermal rests or arise de novo secondary to the activation of some angiogenic signaling is uncertain. The similarity between the proliferative phase of wound healing and the growth of hemangiomas suggests a prominent etiogenic role of disordered angiogenesis as the precipitating cause of hemangiomas. Furthermore, the increased numbers of mast cells in hemangiomas, through their production of heparin, influences the migration of capillary endothelial cells. Finally, the in vitro identification of selective steroid inhibition of angiogenesis through heparin binding supports the clinical experience of hastened regression with steroid therapy.

By comparison, vascular malformations represent abnormal embryonic and fetal morphogenesis during the retiform stage of development of endothelial channels (approximately day 48 of human embryogenesis). As such, these lesions are neither neoplastic nor proliferative; rather, they grow commensurate with the child. Vascular malformations are best characterized by their principal cell type, the degree of blood or lymph flow (which may influence clinical symptoms), and the structures involved. Coincident with their underlying dysmorphogenic nature, these lesions may involve elements of different vascular channels.

Frequency

United States

Hemangiomas are the most common benign tumor observed in infancy, occurring in approximately 10% of white infants. These lesions are observed more commonly in premature infants weighing less than 1000 grams (prevalence as high as 30%). Capillary vascular malformations occur in 3 per 1000 infants.

Mortality/Morbidity

  • Hemangiomas: Complete involution occurs in 70-90% of patients; however, minor atrophic scars or residual ectatic vessels may remain. In the remaining 10-30% of patients, residual, baggy, atrophic skin; excess fibrofatty tissue; and even severe disfigurement may develop. Hemangiomas may also occur in areas where vital structures are compressed (see Complications).
  • Vascular malformations: These lesions do not improve or resolve with time (see Complications).

Race

  • Hemangiomas are less common in African American and Asian infants.

Sex

  • The female-to-male ratio for hemangiomas is 3:1. The female-to-male ratio for vascular malformations is 1:1.

Age

  • Hemangiomas: The infant is healthy but develops a red lesion during the first few weeks of life. The lesion continues to grow for 6-18 months and then reaches a plateau. Spontaneous involution occurs, which may last for a number of years.
  • Vascular malformations: All are present at birth. The lesion grows proportionately with the child and is permanent.

Clinical

History

  • Hemangioma
    • Parents often describe a small red dot appearing during the first few weeks of life. Initially, parents may mistake this lesion for a scratch that does not heal. The lesion then grows disproportionately fast compared with the child.
    • Hemangiomas exhibit spontaneous involution, but this process may continue for years. By the time the patients are aged 5 years, 50% of all hemangiomas resolve; by age 7 years, 70% resolve.
    • A residual skin deformity, such as excess fibrofatty tissue or cutaneous telangiectasia, may persist.
    • Those hemangiomas that show signs of involution by age 3 years have better cosmetic results, whereas lesions that are ulcerated always leave residual scars.
    • The head and neck area is involved in 60% of cases, followed by the trunk and then the extremities.
    • Multiple hemangiomas occur in as many as 20% of patients.
  • Vascular malformations
    • These lesions always are present at birth. They may be subtle at first, but the color does not fade and often darkens.
    • The growth of vascular malformations is proportionate to the growth of the child and never extends beyond its initial boundaries.
    • Capillary vascular malformations (port-wine stain) roughly follow sensory nerve distribution.3,4
    • Venous malformations may not be clinically evident at birth but become more evident as the child ages.
    • Aching pain has been associated with extremity lesions.
    • Patients typically have a strong family history of varicose veins.

Physical

  • Hemangioma
    • Serial physical examinations reliably distinguish between hemangiomas and vascular malformations.
    • The key feature for hemangioma is disproportionate growth compared to the child.
    • Superficial hemangiomas are characterized by a bright strawberry-red pigmentation.
    • Deeper hemangiomas appear as purple- or blue-pigmented lesions.
    • Rapid growth occurs over the next 3-6 months.
    • Plateau and cessation of growth usually occur when patients are aged 6-18 months.
    • Involution occurs over years. Involution is often preceded by a graying appearance and softer tissue turgor of the lesion.
  • Vascular malformations
    • Capillary vascular malformations are initially pale with normal overlying skin texture but may darken as the patient ages.
    • Nodularity and a darker purple pigmentation also may occur in adulthood because of increasing dilation of the dermal vessels.
    • Venous malformations become more evident as the child grows.
    • These malformations gradually dilate and may cause distortion of facial features.
  • Arteriovenous malformations may appear similar to venous malformations. In addition, they may demonstrate increased warmth, an audible bruit, a palpable thrill, or visible pulsations. Hypertrophy of the involved limb or structure is more common with arteriovenous malformations than with simple venous malformations.

Causes

  • Hemangioma
    • Hormonal influence is suggested by the 3:1 female-to-male ratio.
    • The mechanism by which angiogenesis is stimulated and then turned off is not known.
  • Vascular malformations
    • Capillary vascular malformations possibly occur because of a lack of proper sympathetic vasomotor control.
    • Venous malformations are due to errors in development of the venous system and may result in hypoplasia, hyperplasia, and aplasia of the deep and superficial systems.

More on Arteriovenous Malformations

Overview: Arteriovenous Malformations
Differential Diagnoses & Workup: Arteriovenous Malformations
Treatment & Medication: Arteriovenous Malformations
Follow-up: Arteriovenous Malformations
Multimedia: Arteriovenous Malformations
References
Further Reading

References

  1. Castori M, Majore S, Binni F, Grammatico P. Paradoxical association of extensive nevus flammeus together with unilateral lower limb and breast hypoplasia. Am J Med Genet A. Feb 2009;149A(2):266-7. [Medline].

  2. Gao XH, Wang LL, Zhang L, Hong YX, Wei H, Chen HD. Familial nevus flammeus associated with early onset cherry angiomas. Int J Dermatol. Dec 2008;47(12):1284-6. [Medline].

  3. Alster TS, Tanzi EL. Combined 595-nm and 1,064-nm Laser Irradiation of Recalcitrant and Hypertrophic Port-Wine Stains in Children and Adults. Dermatol Surg. Apr 9 2009;[Medline].

  4. Tierney EP, Hanke CW. Treatment of nodules associated with port wine stains with CO2 laser: case series and review of the literature. J Drugs Dermatol. Feb 2009;8(2):157-61. [Medline].

  5. Matsuda D, Iwamura M, Baba S. Cavernous hemangioma of the adrenal gland. Int J Urol. Apr 2009;16(4):424. [Medline].

  6. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg. Mar 1982;69(3):412-22. [Medline].

  7. Qing Y, Cen Y, Xu X, Duan W, Liu Y. [Surgical treatment of hemangioma and vascular malformation in body surface]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. Mar 2009;23(3):325-7. [Medline].

  8. Tongers J, Widera C, Kempf T, Drexler H, Westhoff-Bleck M. Two vascular arteriovenous malformations with left-to-right shunting and right-heart failure in a single patient. Int J Cardiol. Apr 30 2009;[Medline].

  9. Abe S. Local steroid therapy of adnexal strawberry hemangiomas in infants-long term follow-up. Eur J Plast Surg. 1986;9:29.

  10. Coffin CM, Dehner LP, O'Shea PA. Vascular tumors. In: Pediatric Soft Tissue Tumors: A Clinical, Pathological, and Therapeutic Approach. Baltimore, Md: Lippincott, Williams & Wilkins; 1997:. 40-79.

  11. Kim EJ, Halim AX, Dowd CF. The relationship of coexisting extranidal aneurysms to intracranial hemorrhage in patients harboring brain arteriovenous malformations. Neurosurgery. Jun 2004;54(6):1349-57; discussion 1357-8.

  12. Low DW. Hemangiomas and vascular malformations. Semin Pediatr Surg. May 1994;3(2):40-61. [Medline].

  13. Steinmetz OK, Palerme LP. Images in clinical medicine. Acquired arteriovenous fistula. N Engl J Med. May 20 2004;350(21):2180. [Medline].

  14. White CW, Wolf SJ, Korones DN, et al. Treatment of childhood angiomatous diseases with recombinant interferon alfa-2a. J Pediatr. Jan 1991;118(1):59-66. [Medline].

Further Reading

Clinical guidelines

Skin cancer.
Finnish Medical Society Duodecim - Professional Association.  2001 Apr 30 (revised 2005 May 25).  Various pagings.  NGC:004600

ACR Appropriateness Criteria® soft tissue masses.
American College of Radiology - Medical Specialty Society.  1995 (revised 2005).  6 pages.  NGC:004784


Clinical trials

Genetic Basis of Hemangiomas

Personalized Interactive Laser Therapy of Port Wine Stain

Arteriovenous Fistula Tissue Bank

Propranolol in Capillary Hemangiomas

Related eMedicine topics

Arteriovenous Malformations   (Neurology)

Arteriovenous Fistulas

Hemangioblastoma

Hemangiomas, Hepatic

Renal Arteriovenous Malformation

Osler-Weber-Rendu Disease

Dandy-Walker Malformation

Klippel-Trenaunay-Weber Syndrome

Sturge-Weber Syndrome

Keywords

arteriovenous malformations, hemangiomas, vascular malformations, capillary hemangioma, cavernous hemangioma, strawberry nevus, port-wine stain, portwine stain, port wine stain, arteriovenous fistula, nevus flammeus, vascular anomaly, cherry hemangioma, Klippel-Trenaunay syndrome, KTS, Dandy-Walker syndrome, Sturge-Weber syndrome, Parkes Weber syndrome, Osler-Weber-Rendu syndrome, von Hippel-Lindau syndrome, macular stains, stork bites, angel's kiss, angels kisses, salmon patch, telangiectasias, spider veins, birthmark, birth mark

Contributor Information and Disclosures

Author

Steven L Lee, MD, Chief, Pediatric Surgery, Department of Surgery, Kaiser-Permanente, Los Angeles Medical Center
Steven L Lee, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Pediatrics, American College of Surgeons, American Pediatric Surgical Association, Association for Academic Surgery, Society of American Gastrointestinal and Endoscopic Surgeons, and Society of Laparoendoscopic Surgeons
Disclosure: Nothing to disclose.

Coauthor(s)

Devin P Puapong, MD, Fellow, Division of Pediatric Surgery, University of Oklahoma Health Sciences Center
Disclosure: Nothing to disclose.

Jeffrey J DuBois, MD, Consulting Staff, Division of Pediatric Surgery, Kaiser Permanente, North Sacramento Medical Center
Jeffrey J DuBois, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Pediatrics, American College of Surgeons, American Pediatric Surgical Association, Association for Academic Surgery, California Medical Association, Society for Surgery of the Alimentary Tract, Society of American Gastrointestinal and Endoscopic Surgeons, and Society of Critical Care Medicine
Disclosure: Nothing to disclose.

Medical Editor

Richard M Stillman, MD, FACS, Honorary Medical Staff, Northwest Medical Center; Former Chief of Staff and Medical Director, Wound Healing Center, Department of Surgery, Northwest Medical Center
Richard M Stillman, MD, FACS is a member of the following medical societies: American College of Angiology, American College of Surgeons, Association for Academic Surgery, and Society of University Surgeons
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Vincent Lopez Rowe, MD, Assistant Professor of Surgery, Department of Surgery, Division of Vascular Surgery, University of Southern California Medical Center
Vincent Lopez Rowe, MD is a member of the following medical societies: American College of Surgeons, Association for Academic Surgery, Peripheral Vascular Surgery Society, Society for Clinical Vascular Surgery, and Society for Vascular Surgery
Disclosure: Nothing to disclose.

CME Editor

Paolo Zamboni, MD, Professor of Surgery, Chief of Day Surgery Unit, Chair of Vascular Diseases Center, University of Ferrara, Italy
Paolo Zamboni, MD is a member of the following medical societies: American Venous Forum and New York Academy of Sciences
Disclosure: Nothing to disclose.

Chief Editor

William H Pearce, MD, Chief, Division of Vascular Surgery, Violet and Charles Baldwin Professor of Vascular Surgery, Department of Surgery, Northwestern University School of Medicine
William H Pearce, MD is a member of the following medical societies: American College of Surgeons, American Heart Association, American Surgical Association, Association for Academic Surgery, Association of VA Surgeons, Central Surgical Association, New York Academy of Sciences, Society for Vascular Surgery, Society of Critical Care Medicine, Society of University Surgeons, and Western Surgical Association
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.